List of Tables
Table 1. Global Hypogonadism Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hypogonadism Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hypogonadism Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hypogonadism Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Hypogonadism Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hypogonadism Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hypogonadism Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hypogonadism Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hypogonadism Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hypogonadism Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hypogonadism Drug, Product Type & Application
Table 12. Global Key Manufacturers of Hypogonadism Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hypogonadism Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypogonadism Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hypogonadism Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hypogonadism Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Hypogonadism Drug Sales Market Share by Region (2020-2025)
Table 19. Global Hypogonadism Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Hypogonadism Drug Sales Market Share by Region (2026-2031)
Table 21. Global Hypogonadism Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hypogonadism Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Hypogonadism Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hypogonadism Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Hypogonadism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hypogonadism Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Hypogonadism Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Hypogonadism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hypogonadism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hypogonadism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hypogonadism Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Hypogonadism Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Hypogonadism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hypogonadism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hypogonadism Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hypogonadism Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Hypogonadism Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Hypogonadism Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hypogonadism Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hypogonadism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hypogonadism Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Hypogonadism Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Hypogonadism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hypogonadism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hypogonadism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hypogonadism Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Hypogonadism Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Hypogonadism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hypogonadism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hypogonadism Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Hypogonadism Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Hypogonadism Drug Sales Market Share by Type (2020-2025)
Table 53. Global Hypogonadism Drug Sales Market Share by Type (2026-2031)
Table 54. Global Hypogonadism Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hypogonadism Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hypogonadism Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Hypogonadism Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Hypogonadism Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Hypogonadism Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Hypogonadism Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Hypogonadism Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Hypogonadism Drug Sales Market Share by Application (2020-2025)
Table 63. Global Hypogonadism Drug Sales Market Share by Application (2026-2031)
Table 64. Global Hypogonadism Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hypogonadism Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hypogonadism Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Hypogonadism Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Hypogonadism Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Hypogonadism Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Allergan Company Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Allergan Hypogonadism Drug Product
Table 74. Allergan Recent Developments/Updates
Table 75. AbbVie Company Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AbbVie Hypogonadism Drug Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Endo Pharmaceuticals Company Information
Table 81. Endo Pharmaceuticals Description and Business Overview
Table 82. Endo Pharmaceuticals Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Endo Pharmaceuticals Hypogonadism Drug Product
Table 84. Endo Pharmaceuticals Recent Developments/Updates
Table 85. Pfizer Inc. Company Information
Table 86. Pfizer Inc. Description and Business Overview
Table 87. Pfizer Inc. Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Inc. Hypogonadism Drug Product
Table 89. Pfizer Inc. Recent Developments/Updates
Table 90. Clarus Therapeutics, Inc. Company Information
Table 91. Clarus Therapeutics, Inc. Description and Business Overview
Table 92. Clarus Therapeutics, Inc. Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Clarus Therapeutics, Inc. Hypogonadism Drug Product
Table 94. Clarus Therapeutics, Inc. Recent Developments/Updates
Table 95. Aytu BioScience, Inc. Company Information
Table 96. Aytu BioScience, Inc. Description and Business Overview
Table 97. Aytu BioScience, Inc. Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Aytu BioScience, Inc. Hypogonadism Drug Product
Table 99. Aytu BioScience, Inc. Recent Developments/Updates
Table 100. Antares Pharma Company Information
Table 101. Antares Pharma Description and Business Overview
Table 102. Antares Pharma Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Antares Pharma Hypogonadism Drug Product
Table 104. Antares Pharma Recent Developments/Updates
Table 105. Upsher-Smith Laboratories, Inc. Company Information
Table 106. Upsher-Smith Laboratories, Inc. Description and Business Overview
Table 107. Upsher-Smith Laboratories, Inc. Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Upsher-Smith Laboratories, Inc. Hypogonadism Drug Product
Table 109. Upsher-Smith Laboratories, Inc. Recent Developments/Updates
Table 110. Beijing Shuanghe Pharmaceutical Co., Ltd Company Information
Table 111. Beijing Shuanghe Pharmaceutical Co., Ltd Description and Business Overview
Table 112. Beijing Shuanghe Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Beijing Shuanghe Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 114. Beijing Shuanghe Pharmaceutical Co., Ltd Recent Developments/Updates
Table 115. Tianjin Jinyao Amino Acid Co., Ltd Company Information
Table 116. Tianjin Jinyao Amino Acid Co., Ltd Description and Business Overview
Table 117. Tianjin Jinyao Amino Acid Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Tianjin Jinyao Amino Acid Co., Ltd Hypogonadism Drug Product
Table 119. Tianjin Jinyao Amino Acid Co., Ltd Recent Developments/Updates
Table 120. Shanghai General Pharmaceutical Co., Ltd Company Information
Table 121. Shanghai General Pharmaceutical Co., Ltd Description and Business Overview
Table 122. Shanghai General Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Shanghai General Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 124. Shanghai General Pharmaceutical Co., Ltd Recent Developments/Updates
Table 125. Tianjin Lisheng Pharmaceutical Co., Ltd Company Information
Table 126. Tianjin Lisheng Pharmaceutical Co., Ltd Description and Business Overview
Table 127. Tianjin Lisheng Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Tianjin Lisheng Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 129. Tianjin Lisheng Pharmaceutical Co., Ltd Recent Developments/Updates
Table 130. Chengde Jiulong Pharmaceutical Co., Ltd Company Information
Table 131. Chengde Jiulong Pharmaceutical Co., Ltd Description and Business Overview
Table 132. Chengde Jiulong Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Chengde Jiulong Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 134. Chengde Jiulong Pharmaceutical Co., Ltd Recent Developments/Updates
Table 135. Harbin Pharmaceutical Group Company Information
Table 136. Harbin Pharmaceutical Group Description and Business Overview
Table 137. Harbin Pharmaceutical Group Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Harbin Pharmaceutical Group Hypogonadism Drug Product
Table 139. Harbin Pharmaceutical Group Recent Developments/Updates
Table 140. Shenyang Keda Pharmaceutical Co., Ltd Company Information
Table 141. Shenyang Keda Pharmaceutical Co., Ltd Description and Business Overview
Table 142. Shenyang Keda Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Shenyang Keda Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 144. Shenyang Keda Pharmaceutical Co., Ltd Recent Developments/Updates
Table 145. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
Table 146. Zhejiang Xianju Pharmaceutical Co., Ltd Description and Business Overview
Table 147. Zhejiang Xianju Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Zhejiang Xianju Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 149. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Hypogonadism Drug Distributors List
Table 153. Hypogonadism Drug Customers List
Table 154. Hypogonadism Drug Market Trends
Table 155. Hypogonadism Drug Market Drivers
Table 156. Hypogonadism Drug Market Challenges
Table 157. Hypogonadism Drug Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hypogonadism Drug
Figure 2. Global Hypogonadism Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hypogonadism Drug Market Share by Type: 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Hypogonadism Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Hypogonadism Drug Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Specialist Clinic
Figure 11. Others
Figure 12. Global Hypogonadism Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hypogonadism Drug Market Size (2020-2031) & (US$ Million)
Figure 14. Global Hypogonadism Drug Sales (2020-2031) & (K Units)
Figure 15. Global Hypogonadism Drug Average Price (US$/Unit) & (2020-2031)
Figure 16. Hypogonadism Drug Report Years Considered
Figure 17. Hypogonadism Drug Sales Share by Manufacturers in 2024
Figure 18. Global Hypogonadism Drug Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Hypogonadism Drug Players: Market Share by Revenue in Hypogonadism Drug in 2024
Figure 20. Hypogonadism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Hypogonadism Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Hypogonadism Drug Sales Market Share by Country (2020-2031)
Figure 23. North America Hypogonadism Drug Revenue Market Share by Country (2020-2031)
Figure 24. United States Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Hypogonadism Drug Sales Market Share by Country (2020-2031)
Figure 27. Europe Hypogonadism Drug Revenue Market Share by Country (2020-2031)
Figure 28. Germany Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Hypogonadism Drug Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Hypogonadism Drug Revenue Market Share by Region (2020-2031)
Figure 35. China Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Hypogonadism Drug Sales Market Share by Country (2020-2031)
Figure 45. Latin America Hypogonadism Drug Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Hypogonadism Drug Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Hypogonadism Drug Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Hypogonadism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Hypogonadism Drug by Type (2020-2031)
Figure 55. Global Revenue Market Share of Hypogonadism Drug by Type (2020-2031)
Figure 56. Global Hypogonadism Drug Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Hypogonadism Drug by Application (2020-2031)
Figure 58. Global Revenue Market Share of Hypogonadism Drug by Application (2020-2031)
Figure 59. Global Hypogonadism Drug Price (US$/Unit) by Application (2020-2031)
Figure 60. Hypogonadism Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
